(Conrodventurelab.com)
Patricia Conrod is a Clinical Psychologist and Professor of Psychiatry at Universite de Montreal. Her research team is based at the CHU Sainte-Justine Mother and Child Hospital Centre in Montreal. She was previously a Senior Clinical Lecturer in the Addictions Department, King’s College London (2003-2010). Her research focuses on cognitive, personality and biological risk factors for the development and maintenance of drug abuse and the factors that mediate the co-occurrence of addictive behaviours with other mental disorders. Her research findings have led to the development of new approaches to substance abuse treatment and prevention that target personality risk factors and the underlying motivational determinants of drug use in subtypes of substance misusers. She developed the Preventure Program, which is identified as an evidence-based drug and alcohol prevention program by a number of national registries of evidence-based programs and the U.S. Surgeon General’s Report on Addiction. Dr. Conrod was a member of the King’s College London Research Ethics Committee (2005-2010) and served as Chair of the Institute of Psychiatry Research Ethics Committee (2008-2010). She is an Associate Editor of Current Reviews in Drug Abuse and consults to the UN and the European Commission on guidelines for drug and alcohol prevention and has published extensively on this issue. Her research is funded by the Canadian Institutes of Health Research, Fondation de Recherche du Quebec - Santé, European Commission (Health and Humanities/Social Sciences), Medical Research Council-UK (MRC), National Health and Medical Research Council - Australia (NHMRC), and the U.S. National Institutes of Health.
Canadian Institutes of Health Research (CIHR), ERA-NET, Fonds de recherche du Québec – Santé (FRSQ), U.S. National Institutes of Health, Medical and Health Research Council – Australia.
Almost $40 million in grants from the Innovation Fund of the Canada Foundation for Innovation
CHUSJ Psychiatry Department and Venture Lab
Changes in adolescent social media use and television use predict increases in symptoms of depression.
A study led by researchers at CHU Sainte-Justine confirms that cannabis use is related to impaired and lasting effects on adolescent cognitive development
A new study led by researchers at CHU Sainte-Justine showed that we can predict who will become a bully and how to change their path with targeted neurocognitive strategies.
A study led by a research team at CHU Sainte-Justine confirms that cannabis use precedes and predicts psychotic symptoms in a population-based study of Canadian youth
An international research team has demonstrated that an exaggerated emotional brain response to non-threatening information predicts emergence of clinically psychotic symptoms
A full day of scientific presentations opened to the public to inform the debate on cannabis legalization in Canada
Real-world trial of school-based interventions shows at-risk teenagers can be influenced
“Big Data” Combines with Crowd Sourcing to Accelerate Medical Research
Study suggests ways to treat these deficits before the psychiatric symptoms develop
Researchers discover a variety of factors that determine, with 70% accuracy, which kids will become binge drinkers
Two 90-minute group sessions in high schools significantly reduced anxiety, depression and behaviour problems over a two-year period.
Personality-targeted interventions delivered by trained teachers and school staff decrease alcohol misuse in at-risk teens and delay their classmates’ alcohol uptake.